Canadian Pharmacy Blog

The Pharmion Corporation has announced the approval of azacitidine for injectable suspension (Vidaza™) to treat a cancer-like, bone-marrow illness that sometimes progresses to leukemia. Vidaza™ is used to treat myelodys-plastic syndromes, a collection of disorders in which the bone marrow does not make enough normal blood cells. actos online Pharmion will have as much as [...]

The FDA has approved a New Drug Application (NDA) supplement to add intravenous (IV) use as a new route of administration for azacitidine (Vidaza, Pharmion). This agent, which is indicated for the treatment of myelodys-plastic syndromes (MDS), may now be infused over a period of 10 to 40 minutes in a clinic or hospital setting. [...]